Institute of Cancer Therapeutics
The Institute of Cancer Therapeutics houses a multidisciplinary team of researchers in the field of drug design, synthesis, screening and pharmacology. Our purpose built institute is configured to integrate all the elements of the preclinical drug and biomarker discovery process, in keeping with our mission to research and develop new cancer treatments.
The Institute has significant cancer charity, UK research council and commercial sponsorship to facilitate the progression of new therapies. To support follow on from preclinical proof of mechanism studies for new agents, where appropriate the institute collaborates with its spin out company Incanthera Ltd.
The Knowledge Transfer activities of the Institute provide collaborative research support to the pharmaceutical and biotechnology industries.